Last update 06 Dec 2024

UBT-251

Overview

Basic Info

Drug Type
Synthetic peptide
Synonyms
UBT 251, UBT-251, UBT251
Target
GCGR x GIPR x GLP-1R
Mechanism
GCGR agonists(Glucagon receptor agonists), GIPR agonists(Gastric inhibitory polypeptide receptor agonists), GLP-1R agonists(Glucagon-like peptide 1 receptor agonists)
Therapeutic Areas
Digestive System DisordersEndocrinology and Metabolic Disease
Active Indication
Diabetes Mellitus, Type 2Nonalcoholic SteatohepatitisObesity
Inactive Indication-
Originator Organization
Federal Biotechnology (Zhuhai Hengqin) Co., Ltd.
Active Organization
Federal Biotechnology (Zhuhai Hengqin) Co., Ltd.
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

3
Clinical Trials associated with UBT-251
CTR20232997 / RecruitingPhase 1
评估健康受试者单次皮下注射UBT251的安全性、耐受性、药代动力学、药效动力学的Ⅰ期临床试验
[Translation] A Phase I clinical trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of a single subcutaneous injection of UBT251 in healthy subjects
CTR20233938 / Not yet recruitingPhase 1
评估超重/肥胖患者多次皮下注射UBT251的安全性、耐受性、药代动力学、药效动力学的Ⅰ期临床试验
[Translation] A Phase I clinical trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple subcutaneous injections of UBT251 in overweight/obese patients
CTR20234009 / Not yet recruitingPhase 1
评估成人2型糖尿病患者多次皮下注射UBT251的安全性、耐受性、药代动力学、药效动力学的Ⅰ期临床试验
[Translation] A Phase I clinical trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple subcutaneous injections of UBT251 in adults with type 2 diabetes
100 Clinical Results associated with UBT-251
Login to view more data
100 Translational Medicine associated with UBT-251
Login to view more data
100 Patents (Medical) associated with UBT-251
Login to view more data
100 Deals associated with UBT-251
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetes Mellitus, Type 2Phase 1
CN
Federal Biotechnology (Zhuhai Hengqin) Co., Ltd.
10 Oct 2023
Nonalcoholic SteatohepatitisPhase 1
CN
Federal Biotechnology (Zhuhai Hengqin) Co., Ltd.
10 Oct 2023
ObesityPhase 1
CN
Federal Biotechnology (Zhuhai Hengqin) Co., Ltd.
10 Oct 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free